A new Study Uncovers Unprecedented Socioeconomic Benefits of Obesity Treatment in Saudi Arabia Riyadh, …
Tag:
Lilly
-
-
Lifestyle & Healthslider
Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity
by Karine Ayoubby Karine AyoubIn ATTAIN-2, orforglipron met the primary and all key secondary endpoints, with compelling efficacy results …